» Articles » PMID: 26882502

More Effective Drugs Lead to Harder Selective Sweeps in the Evolution of Drug Resistance in HIV-1

Overview
Journal Elife
Specialty Biology
Date 2016 Feb 17
PMID 26882502
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

In the early days of HIV treatment, drug resistance occurred rapidly and predictably in all patients, but under modern treatments, resistance arises slowly, if at all. The probability of resistance should be controlled by the rate of generation of resistance mutations. If many adaptive mutations arise simultaneously, then adaptation proceeds by soft selective sweeps in which multiple adaptive mutations spread concomitantly, but if adaptive mutations occur rarely in the population, then a single adaptive mutation should spread alone in a hard selective sweep. Here, we use 6717 HIV-1 consensus sequences from patients treated with first-line therapies between 1989 and 2013 to confirm that the transition from fast to slow evolution of drug resistance was indeed accompanied with the expected transition from soft to hard selective sweeps. This suggests more generally that evolution proceeds via hard sweeps if resistance is unlikely and via soft sweeps if it is likely.

Citing Articles

Signatures of selective sweeps in continuous-space populations.

Chotai M, Wei X, Messer P bioRxiv. 2024; .

PMID: 39091822 PMC: 11291165. DOI: 10.1101/2024.07.26.605365.


Building pyramids against the evolutionary emergence of pathogens.

Gandon S, Guillemet M, Gatchitch F, Nicot A, Renaud A, Tremblay D Proc Biol Sci. 2024; 291(2018):20231529.

PMID: 38471546 PMC: 10932699. DOI: 10.1098/rspb.2023.1529.


Tensor Decomposition-based Feature Extraction and Classification to Detect Natural Selection from Genomic Data.

Amin M, Hasan M, Arnab S, DeGiorgio M Mol Biol Evol. 2023; 40(10).

PMID: 37772983 PMC: 10581699. DOI: 10.1093/molbev/msad216.


Steering and controlling evolution - from bioengineering to fighting pathogens.

Lassig M, Mustonen V, Nourmohammad A Nat Rev Genet. 2023; 24(12):851-867.

PMID: 37400577 PMC: 11137064. DOI: 10.1038/s41576-023-00623-8.


Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy.

Salimi-Jeda A, Esghaei M, Keyvani H, Bokharaei-Salim F, Teimoori A, Abdoli A Heliyon. 2022; 8(9):e10483.

PMID: 36158108 PMC: 9489754. DOI: 10.1016/j.heliyon.2022.e10483.


References
1.
Daborn P, Boundy S, Yen J, Pittendrigh B, ffrench-Constant R . DDT resistance in Drosophila correlates with Cyp6g1 over-expression and confers cross-resistance to the neonicotinoid imidacloprid. Mol Genet Genomics. 2002; 266(4):556-63. DOI: 10.1007/s004380100531. View

2.
Larder B, Kohli A, Kellam P, Kemp S, KRONICK M, Henfrey R . Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing. Nature. 1993; 365(6447):671-3. DOI: 10.1038/365671a0. View

3.
Pennings P, Kryazhimskiy S, Wakeley J . Loss and recovery of genetic diversity in adapting populations of HIV. PLoS Genet. 2014; 10(1):e1004000. PMC: 3900388. DOI: 10.1371/journal.pgen.1004000. View

4.
Smith J, Haigh J . The hitch-hiking effect of a favourable gene. Genet Res. 1974; 23(1):23-35. View

5.
Rhee S, Gonzales M, Kantor R, Betts B, Ravela J, Shafer R . Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res. 2003; 31(1):298-303. PMC: 165547. DOI: 10.1093/nar/gkg100. View